US biotech firm Inovio reports encouraging coronavirus vaccine results

in Latest News

The US biotech firm Inovio reported preliminary but encouraging results Tuesday from tests of an experimental coronavirus vaccine.

Administered to 40 volunteers, it triggered an immune system response in 94 percent of those who completed the so-called phase one clinical trial, meaning they received two injections, four weeks apart.

Inovio’s vaccine, called INO-4800, is designed to inject DNA into a person so as to set off a specific immune system response against the SARS-CoV-2 virus.

The medication is injected under the skin with a needle, then activated with a device that resembles a toothbrush, which delivers an electrical impulse for a fraction of a second, allowing the DNA …

Keep on reading: US biotech firm Inovio reports encouraging coronavirus vaccine results

The Philippine Daily Inquirer, popularly known as the Inquirer, is an English-language newspaper in the Philippines. Founded in 1985, it is often regarded as the Philippines' newspaper of record.

Leave a Reply

Your email address will not be published.

*